Skip to main content
Distinct toxicity profiles for anti-BCMA myeloma therapies
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Distinct toxicity profiles for anti-BCMA myeloma therapies
User login
Username
Password
Reset your password
Concept
Lead
score
Multiple Myeloma
1
1
Biologic Therapy
0
0.94
CAR-T
0
0.89
Toxicology
0
0.69
Adverse Effects
0
0.32
Biomedical Technology
0
0.32
Neurotoxicity
0
0.32
Patient Safety
0
0.29
Pneumonia
0
0.29
Antigens
0
0.21
Cytokines
0
0.21
Cytomegalovirus
0
0.21
Healthcare and Medical Technology
0
0.21
COVID-19
0
0.12
Bell Palsy
0
0.11
Blood
0
0.11
Cancer
0
0.11
Data Collection
0
0.11
Hematology
0
0.11
Intellectual Property
0
0.11
Medication Errors
0
0.11
Parkinsonian
0
0.11
Receptors
0
0.11
Refractory
0
0.11
Transplantation
0
0.11
Travel Medicine
0
0.11
Parkinson Disease
0
0.07
Sepsis
0
0.07
Specialty
Lead
score
Hematology-Oncology
1
1
Family Medicine/Primary Care
0
1
Pulmonary Medicine
0
0.77
Emergency Medicine
0
0.75
Pharmacist
0
0.71
Public Health & Prevention
0
0.63
Infectious Diseases
0
0.6
Internal Medicine
0
0.51
Neurology & Neurosurgery
0
0.47
Critical Care
0
0.29
Hospital Medicine
0
0.07
Transplantation
0
0.07
Edit Tags